To achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies.
Find out MoreDate | Source | Headline | |
---|---|---|---|
15th Apr 2020 | 6:22 pm | RNS | Net Asset Value(s) |
9th Apr 2020 | 4:22 pm | RNS | Notice of Annual Report |
1st Apr 2020 | 6:00 pm | RNS | Series B2 Financing in iTeos Therapeutics |
1st Apr 2020 | 4:00 pm | RNS | Name Change of Administrator and Company Secretary |
18th Mar 2020 | 12:23 pm | RNS | Director/PDMR Shareholding |
18th Mar 2020 | 11:56 am | RNS | Director/PDMR Shareholding |
13th Mar 2020 | 7:00 am | RNS | Net Asset Value(s) |
2nd Mar 2020 | 7:00 am | RNS | Total Voting Rights |
26th Feb 2020 | 7:00 am | RNS | Issue of Equity |
19th Feb 2020 | 7:00 am | RNS | Issue of Equity |
17th Feb 2020 | 5:10 pm | RNS | Announcement of Share Issuance |
14th Feb 2020 | 7:00 am | RNS | Net Asset Value(s) |
3rd Feb 2020 | 7:00 am | RNS | Total Voting Rights |
29th Jan 2020 | 7:00 am | RNS | Issue of Equity |
27th Jan 2020 | 7:00 am | RNS | Issue of Equity |
17th Jan 2020 | 4:30 pm | RNS | Issue of Equity |
16th Jan 2020 | 7:00 am | RNS | Issue of Equity |
15th Jan 2020 | 7:00 am | RNS | Net Asset Value(s) |
23rd Dec 2019 | 11:28 am | RNS | Holding(s) in Company |
16th Dec 2019 | 5:57 pm | RNS | Net Asset Value(s) |
21st Nov 2019 | 3:45 pm | RNS | RTW leads $100M Financing in Avidity Biosciences |
5th Nov 2019 | 10:00 am | RNS | Holding(s) in Company |
5th Nov 2019 | 9:44 am | RNS | Holding(s) in Company |
1st Nov 2019 | 7:00 am | RNS | Total Voting Rights |
30th Oct 2019 | 3:16 pm | RNS | Holding(s) in Company |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.